Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT00644358

Public ClinicalTrials.gov record NCT00644358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open label 52-week clinical trial is designed to assess the safety and tolerability of vilazodone and to analyze genetic markers of response to vilazodone in adult patients diagnosed with MDD. This study will enroll approximately 600 patients.

Study identification

NCT ID
NCT00644358
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
616 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007 (Actual)
Primary completion
May 31, 2009 (Actual)
Completion
May 31, 2009 (Actual)
Last update posted
Sep 25, 2017

2007 – 2009

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Collaborative Neuroscience Network, Inc. Garden Grove California 92845 —
Affiliated Research Institute San Diego California 92108 —
Collaborative Neuroscience Network, Inc Torrance California 90502 —
Pacific Clinical Research Upland California 91786 —
Radiant Research Denver Colorado 80239 —
CNS Clinical Research Group Coral Springs Florida 33065 —
Gulfcoast Clinical Research Fort Myers Florida 33912 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32216 —
Florida Clinical Research Center, LLC Lady Lake Florida 32159 —
Clinical Neuroscience Solutions, PA Orlando Florida 32806 —
Stedman Clinical Trials Tampa Florida 33613 —
Carman Research Smyrna Georgia 30080 —
Chicago Research Center Chicago Illinois 60634 —
Capstone Clinical Research Libertyville Illinois 60048 —
Davis Clinic Indianapolis Indiana 46260 —
Vince and Associates Clinical Research Overland Park Kansas 66212 —
Capital Clinical Research Associates Rockville Maryland 20852 —
Summit Research Network Farmington Michigan 48336 —
Radiant Research St Louis Missouri 63141 —
Radiant Research Las Vegas Nevada 89146 —
Bioscience Research, LLC Mount Kisco New York 10549 —
Eastside Comprehensive Medical Center New York New York 10021 —
The Medical Research Network, LLC New York New York 10024 —
North Coast Clinical Trials Beachwood Ohio 44122 —
Patient Priority Clinical Sites, LLC Cincinnati Ohio 45242 —
North Star Medical Research, LLC Middleburg Heights Ohio 44130 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Paramount Clinical Research Bridgeville Pennsylvania 15017 —
Introspect of Buxmont Colmar Pennsylvania 18915 —
Suburban Research Associates Media Pennsylvania 19063 —
Clinical Neuroscience Solutions Memphis Tennessee 38119 —
FutureSearch Trials Austin Texas 78756 —
FutureSearch Trials Dallas Texas 75231 —
Croft Group Research Center San Antonio Texas 78229 —
Neuropsychiatric Associates Woodstock Vermont 05091 —
Neuroscience, Inc. Herndon Virginia 20170 —
Dominion Clinical Research Midlothian Virginia 23112 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00644358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2017 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00644358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →